TVTX
NASDAQ · Biotechnology
Travere Therapeutics Inc
$62.76
-1.98 (-3.06%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+146.80%
YTD
+58.81%
Open$64.89
Previous Close$64.74
Day High$64.89
Day Low$62.47
52W High$68.73
52W Low$22.06
Volume—
Avg Volume1.41M
Market Cap6.07B
P/E Ratio—
EPS$-0.50
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$32.84
Above
SMA 200
$24.79
Above
RSI (14)
40.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-40.8% upside
Current
$62.76
$62.76
Target
$37.15
$37.15
$26.93
$37.15 avg
$48.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 504.51M | 381.40M | 873.79M |
| Net Income | -26,268,119 | -17,872,170 | 83.63M |
| Profit Margin | -5.2% | -5.0% | 9.6% |
| EBITDA | -3,714,590 | -2,667,720 | 111.75M |
| Free Cash Flow | — | — | 68.75M |
| Rev Growth | +32.3% | +32.3% | +12.5% |
| Debt/Equity | 2.71 | 2.71 | 0.14 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |